• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Drudgereport

Latest news from around the world

  • Submit
  • Disclaimers
  • About
  • DMCA
  • Privacy Policy
  • Contact
You are here: Home / Pfizer COVID vaccine live updates: FDA holdsbriefing on full approval of shot

Pfizer COVID vaccine live updates: FDA holdsbriefing on full approval of shot

Live Updates On Monday, the U.S. Food and Drug Administration issued the first full authorization for a COVID-19 vaccine, giving full approval to the Pfizer two-dose shot. The Pfizer-BioNTech vaccine, which will be marketed as Comirnaty, is fully authorized for people 16-years-old and older, while people aged 12 through 15 can still receive the vaccine under the emergency use grant. Pifzer’s shot was granted emergency use authorization in December 2020. Administration of a third dose, or booster shot, is also still under emergency use approval for individuals with suppressed immune systems or certain medical conditions, though booster shots will be available to all U.S. citizens in the coming weeks. Janet Woodcock, M.D., the acting FDA commissioner, said in a press release the approval of Comirnaty was a “milestone” for battling the pandemic. “While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” Woodcock said. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval… Read full this story

  • Meningococcal Vaccines Market Offering High-growth Opportunities for Market Players
  • HPV Vaccine
  • Recently Approved Anthrax Treatment Can Cause Joint Damage Among Children
  • Therapeutic Vaccines Market 2016: Global Industry Review, Research, Statistics, and Growth to 2021
  • Vaccines Market 2016: Global Industry Review, Research, Statistics, and Growth to 2021
  • 'SNL' finally spoofs Juliàn Castro, and the former San Antonio mayor approves
  • Miss Samoa steps up to help stop measles spread
  • Causes of Facial Wrinkles
  • Insulin replacement therapy will continue to dominate the market in the next 10 years
  • HS2 change threatens newly-built homes
Pfizer COVID vaccine live updates: FDA holdsbriefing on full approval of shot have 285 words, post on www.newsweek.com at August 23, 2021. This is cached page on Drudgereport. If you want remove this page, please contact us.

Primary Sidebar

RSS Drudgereport

  • Germany’s Merck acquiring chemical business of Mecaro
  • Bitterness persists as PPP tries to move beyond Lee Jun-seok
  • Sexual harassment reported at embassy in the Hague
  • What is ‘Yoononomics’?
  • After 104 days, new prosecutor general finally named

Sponsored Links

  • US commission to conduct assessment of failure of 20-year war in Afghanistan
  • Jennifer Lopez is ‘fuming’ at Ben Affleck’s decision to bash Jennifer Garner in public
  • Mr Bean has amazing £10m car collection
  • Prince William’s secret intention for US move before Prince Harry unearthed
  • State Dept. suggests Afghan Fulbright hopefuls seek other options as program stalls
Copyright © 2022 Drudgereport. Power by Wordpress.
Home - About Us - Contact Us - Disclaimers - DMCA - Privacy Policy - Submit your story